DK1284993T3 - Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater - Google Patents

Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater

Info

Publication number
DK1284993T3
DK1284993T3 DK01945261T DK01945261T DK1284993T3 DK 1284993 T3 DK1284993 T3 DK 1284993T3 DK 01945261 T DK01945261 T DK 01945261T DK 01945261 T DK01945261 T DK 01945261T DK 1284993 T3 DK1284993 T3 DK 1284993T3
Authority
DK
Denmark
Prior art keywords
bordetella
pertactin
parapertussis
bronchiseptica
pertussis
Prior art date
Application number
DK01945261T
Other languages
Danish (da)
English (en)
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1284993T3 publication Critical patent/DK1284993T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01945261T 2000-05-25 2001-05-23 Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater DK1284993T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25
PCT/EP2001/006457 WO2001090143A2 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Publications (1)

Publication Number Publication Date
DK1284993T3 true DK1284993T3 (da) 2008-07-28

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01945261T DK1284993T3 (da) 2000-05-25 2001-05-23 Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater

Country Status (11)

Country Link
US (3) US7070779B2 (enExample)
EP (1) EP1284993B1 (enExample)
JP (1) JP2003533990A (enExample)
AT (1) ATE393166T1 (enExample)
AU (1) AU2001267527A1 (enExample)
CY (1) CY1110430T1 (enExample)
DE (1) DE60133734T2 (enExample)
DK (1) DK1284993T3 (enExample)
ES (1) ES2303833T3 (enExample)
PT (1) PT1284993E (enExample)
WO (1) WO2001090143A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
ATE393166T1 (de) 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
CU23679A1 (es) 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
WO2010131111A1 (en) * 2009-05-11 2010-11-18 Novartis Ag Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
WO2012104820A1 (en) * 2011-02-04 2012-08-09 Pfizer Inc. Compositions for canine respiratory disease complex
JP5833145B2 (ja) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー 免疫原性bordetellabronchiseptica組成物
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
ATE393166T1 (de) 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Also Published As

Publication number Publication date
DE60133734D1 (de) 2008-06-05
PT1284993E (pt) 2008-06-11
DE60133734T2 (de) 2009-05-14
US20030180307A1 (en) 2003-09-25
US6964767B2 (en) 2005-11-15
US7070779B2 (en) 2006-07-04
CY1110430T1 (el) 2012-05-23
WO2001090143A3 (en) 2002-09-26
US20060008474A1 (en) 2006-01-12
ES2303833T3 (es) 2008-09-01
EP1284993A2 (en) 2003-02-26
JP2003533990A (ja) 2003-11-18
EP1284993B1 (en) 2008-04-23
AU2001267527A1 (en) 2001-12-03
US20020192237A1 (en) 2002-12-19
US20040166116A9 (en) 2004-08-26
ATE393166T1 (de) 2008-05-15
WO2001090143A2 (en) 2001-11-29
US7314910B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
CY1110430T1 (el) Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις
HU9904549A (en) Vaccines
CR6540A (es) Trifluorobutenos nematicidas
HRP20041085B1 (hr) Inhibitori hepatitis c virusa
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
NO20050701L (no) 4-pyrrolidino-fenyl-benzyleter derivater
DE60139963D1 (de) Fusionsproteine aus mycobakterium tuberculosis
DK1255815T3 (da) Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DE50204688D1 (de) N-alkylaziridinoprepolymere als dentalmasse
DK0766696T3 (da) Thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser
HUP0303126A2 (hu) Vektorok molekuláknak CD11b-t expresszáló sejtekhez történő szállítására
EP1395283A4 (en) HETEROLOGICAL PROTECTION, INDUCED BY IMMUNIZATION WITH THE INVAPLEX VACCINE
EP1794329A4 (en) ISOLATES OF PIG VIRUS CAUSING REPRODUCTION AND RESPIRATORY SYNDROME AND THEIR USE
DE60132427D1 (de) Gebrauch von opri lipoprotein aus pseudomonas als th1 induzierendes natürliches adjuvans für heterologe antigene
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
MY138326A (en) Process for the preparation of alkylene glycols
AR029468A1 (es) Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
DK0787796T3 (da) Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner
DK0863981T3 (da) Detektering, forebyggelse og behandling af papillomatous digital dermatitis
ATE358675T1 (de) Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde